The Virtual Twin of Processes and Equipment to Support Modular Biomanufacturing

Presented by

Clément Glace, Guillaume Kerboul

About this talk

Time to move pharma manufacturing to the next level! - 34% product quality improvements - 30% reduced manufacturing costs - 28% reduced unplanned downtime - 25% increased throughput Pandemics, shifting drug prices, government healthcare mandates, regulatory requirements, calls for consumer customization—challenges such as these have driven pharmaceutical & biopharma processors to look at ways to streamline operations and reduce costs to manufacture faster. One of the ways this is happening is through modular manufacturing, which allows organizations to produce a variety of products from a single facility with faster changeovers, increased flexibility, and improved overall equipment effectiveness. Register to watch this discussion on how the Virtual Twin of biomanufacturing processes and recipes, as well as the Virtual Twin of buildings, equipment and single-use kits, can help Life Sciences companies and CMOs to implement modular and flexible drug manufacturing and accelerate industrialization, scale-up and tech transfer, leading ultimately to more sustainable drug manufacturing.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (11)
Subscribers (347)
Dassault Systèmes is a science-based company providing technology solutions for innovation. We draw on various branches of science – mathematics, biology, chemistry, physics, geology – to break down silos of knowledge and find the most innovative, sustainable solutions for the future. Subscribe to this channel featuring content for those who develop and bring BioPharma and Medical Device therapies to market for the advancement of human health.